Tuesday, January 06, 2026 | 08:46 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Zydus Wellness Q4 result: Profit rises 14.4% to Rs 171.9 cr on strong sales

The company had posted a consolidated net profit of Rs 150.3 crore in the same quarter of the previous fiscal

Zydus Lifesciences, Zydus

Zydus Wellness Ltd on Monday reported a 14.4 per cent rise in consolidated net profit at Rs 171.9 crore in the fourth quarter. Photo: X@ZydusUniverse

Press Trust of India New Delhi

Listen to This Article

Zydus Wellness Ltd on Monday reported a 14.4 per cent rise in consolidated net profit at Rs 171.9 crore in the fourth quarter ended March 31, 2025, driven by strong performance of its food and nutrition as well as personal care segments.

The company had posted a consolidated net profit of Rs 150.3 crore in the same quarter of the previous fiscal.

The board of the company has approved the sub-division of its stock with one equity share of face value of Rs 10 to be split into five equity shares of face value Rs 2 each, subject to shareholders' approval.

 

Consolidated total revenue from operations in the fourth quarter stood at Rs 910.6 crore, as compared to Rs 778 crore in the year-ago period, Zydus Wellness Ltd said in a regulatory filing. 

Total expenses in the quarter under review were higher at Rs 740.5 crore, as compared to Rs 632.2 crore in the corresponding period a year ago.

With the continued thrust on marketing initiatives, several key brands including Nutralite, Glucon-D, Everyuth, and Nycil continued to perform well during the quarter, the company said.

For 2024-25, consolidated net profit was at Rs 346.9 crore, as compared to Rs 266.9 crore in 2023-24, it added.

The company's FY25 consolidated total revenue from operations stood at Rs 2,708.9 crore, compared to Rs 2,327.8 crore in FY24, it added.

The food and nutrition segment maintained its upward trajectory, registering quarterly growth of 15.4 per cent and 13 per cent growth for FY25.

The personal-care segment continued to demonstrate strong performance, achieving notable double-digit growth of 22.5 per cent for the quarter and 33.4 per cent growth for FY25, the company added.

The board has recommended a final dividend of Rs 6 per equity share of Rs 10 subject to approval of shareholders, at the ensuing annual general meeting (AGM) scheduled to be held on July 30, 2025, Zydus Wellness said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 19 2025 | 2:19 PM IST

Explore News